Ticker
PPCBCompany Name
PROPANC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 8.35M | 1.5 | $ 5.58M |
3/31/2025 | $ 9.74M | 2.24 | $ 4.34M |
12/31/2024 | $ 17.98K | 0 | $ 4.15M |
9/30/2024 | $ 21.53K | 0.01 | $ 4.1M |
6/30/2024 | $ 25.44K | 0.01 | $ 3.79M |
3/31/2024 | $ 12.86K | 0 | $ 3.69M |
12/31/2023 | $ 210.82K | 0.06 | $ 3.76M |
9/30/2023 | $ 145.8K | 0.05 | $ 3.13M |
6/30/2023 | $ 19.04K | 0.01 | $ 3.16M |
3/31/2023 | $ 96.58K | 0.03 | $ 3.06M |
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for PROPANC BIOPHARMA INC is calculated as follows: AssetsC [ $ 15.03K ] / LiabilitesC [ $ 3.06M ]
(=) Current Ratio [ 0 ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |